Hysterectomy. Prolapse of vaginal vault after hysterectomy
Conditions
Interventions
Intervention 1: Intervention group1: Patients in the ginger group receive two 500 mg Vomegan Dineh ginger tablets (manufactured by Dineh Bern Company), each containing 500 mg of ginger, one hour befor
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: No history of cancer No history of high blood pressure Age between 40 to 60 years Ability to swallow the pill used in the study Platelet count above 100000, no history of intestinal obstruction and hepatitis No use of anti-nausea and anti-vomiting drugs or drugs that induce them No history of allergy to ginger No use of blood-thinning and anticoagulant drugs before surgery
Exclusion criteria
Exclusion criteria: Lack of patient's consent to participate in the study Willingness to cooperate Patients who experience cardiopulmonary arrest during surgery Patients who are referred to the intensive care unit for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of nausea. Timepoint: Recovery and 2, 4, 6, 12 and 24 hours after surgery. Method of measurement: Observation.;Vomiting. Timepoint: Recovery and 2, 4, 6, 12 and 24 hours after surgery. Method of measurement: Score 0 to 4.;Sedation. Timepoint: In recovery and 1, 2 and 4 hours after surgery. Method of measurement: Ramsay score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hesamedin Modir
Arak University of Medical Sciences
Outcome results
None listed